{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:07:54Z","timestamp":1785154074371,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,27]]},"DOI":"10.7759\/cureus.113447","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:56:31Z","timestamp":1785153391000},"source":"Crossref","is-referenced-by-count":0,"title":["Nebulized Potassium-Conjugated Linoleic Acid (K-CLA) Therapy in a Patient With Chronic Obstructive Pulmonary Disease and Centrilobular Emphysema: A Case Report"],"prefix":"10.7759","author":[{"given":"Sven T","family":"Jonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Beckworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Global Initiative for Chronic Lung Disease. Global strategy for the prevention, diagnosis and management of chronic obstructive pulmonary disease. 2025 report. (2025). Accessed: July 14, 2026: https:\/\/goldcopd.org."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1900500","article-title":"Update on clinical aspects of chronic obstructive pulmonary disease","volume":"381","author":"Celli BR","year":"2019","unstructured":"Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 2019, 381:1257-66. 10.1056\/NEJMra1900500","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22851","article-title":"Potassium linoleate (isomerized) satisfies the United States Environmental Protection Agency MB-05-16 for hospital disinfectant on hard, non-porous surfaces","volume":"14","author":"Changaris DG","year":"2022","unstructured":"Changaris DG, Carenbauer AL. Potassium linoleate (isomerized) satisfies the United States Environmental Protection Agency MB-05-16 for hospital disinfectant on hard, non-porous surfaces. Cureus. 2022, 14:e22851. 10.7759\/cureus.22851","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-6-36","article-title":"Conjugated linoleic acids as functional food: an insight into their health benefits","volume":"6","author":"Benjamin S","year":"2009","unstructured":"Benjamin S, Spener F. Conjugated linoleic acids as functional food: an insight into their health benefits. Nutr Metab (Lond). 2009, 6:36. 10.1186\/1743-7075-6-36","journal-title":"Nutr Metab (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtm.2016.01.021","article-title":"Evaluation of anti-tubercular activity of linolenic acid and conjugated-linoleic acid as effective inhibitors against Mycobacterium tuberculosis","volume":"9","author":"Choi WH","year":"2016","unstructured":"Choi WH. Evaluation of anti-tubercular activity of linolenic acid and conjugated-linoleic acid as effective inhibitors against Mycobacterium tuberculosis. Asian Pac J Trop Med. 2016, 9:125-9. 10.1016\/j.apjtm.2016.01.021","journal-title":"Asian Pac J Trop Med"},{"key":"ref6","article-title":"Case study using nebulized isomerized linoleic acid (LA) for outpatient treatment of symptomatic COVID-19 [PREPRINT]","author":"Jonsson S","year":"2020","unstructured":"Jonsson S, Mendenhall M, Jonsson C. Case study using nebulized isomerized linoleic acid (LA) for outpatient treatment of symptomatic COVID-19 [PREPRINT]. Europe PMS. 2020,","journal-title":"Europe PMS"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2024.04.021","article-title":"The biophysical function of pulmonary surfactant","volume":"123","author":"Hall SB","year":"2024","unstructured":"Hall SB, Zuo YY. The biophysical function of pulmonary surfactant. Biophys J. 2024, 123:1519-30. 10.1016\/j.bpj.2024.04.021","journal-title":"Biophys J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00004.2021","article-title":"Physiology and pathophysiology of human airway mucus","volume":"102","author":"Hill DB","year":"2022","unstructured":"Hill DB, Button B, Rubinstein M, Boucher RC. Physiology and pathophysiology of human airway mucus. Physiol Rev. 2022, 102:1757-836. 10.1152\/physrev.00004.2021","journal-title":"Physiol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11743-014-1591-4","article-title":"Investigation of micellization and vesiculation of conjugated linoleic acid by means of self-assembling and self-crosslinking","volume":"18(1)","author":"Fan Y","year":"2015","unstructured":"Fan Y, Fang Y, Ma L, et al.. Investigation of micellization and vesiculation of conjugated linoleic acid by means of self-assembling and self-crosslinking. J Surfactants Deterg. 2015, 18(1):179-88. 10.1007\/s11743-014-1591-4","journal-title":"J Surfactants Deterg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.99733","article-title":"The safety of nebulized conjugated linoleic acid for COVID-19 respiratory tract infections","volume":"17","author":"Jonsson ST","year":"2025","unstructured":"Jonsson ST, Beckworth WJ. The safety of nebulized conjugated linoleic acid for COVID-19 respiratory tract infections. Cureus. 2025, 17:e99733. 10.7759\/cureus.99733","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD Assessment Test","volume":"34","author":"Jones PW","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34:648-54. 10.1183\/09031936.00102509","journal-title":"Eur Respir J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler DA","year":"1988","unstructured":"Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988, 93:580-6. 10.1378\/chest.93.3.580","journal-title":"Chest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"The American Thoracic Society","year":"2002","unstructured":"The American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002, 166:111-7. 10.1164\/ajrccm.166.1.at1102","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg GA","year":"1982","unstructured":"Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982, 14:377-81. 10.1249\/00005768-198205000-00012","journal-title":"Med Sci Sports Exerc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70001-3","article-title":"Minimum clinically important difference for the COPD Assessment Test: a prospective analysis","volume":"2","author":"Kon SSC","year":"2014","unstructured":"Kon SSC, Canavan JL, Jones SE, et al.. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014, 2:195-203. 10.1016\/S2213-2600(14)70001-3","journal-title":"Lancet Respir Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall JC","year":"1999","unstructured":"Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999, 54:581-6. 10.1136\/thx.54.7.581","journal-title":"Thorax"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1081\/copd-200050655","article-title":"Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale","volume":"2","author":"Ries AL","year":"2005","unstructured":"Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2005, 2:105-10. 10.1081\/copd-200050655","journal-title":"COPD"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.60.041807.123500","article-title":"Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease","volume":"61","author":"Whitsett JA","year":"2010","unstructured":"Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med. 2010, 61:105-19. 10.1146\/annurev.med.60.041807.123500","journal-title":"Annu Rev Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham BL","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, et al.. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019, 200:e70-88. 10.1164\/rccm.201908-1590ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56238","article-title":"Effect of surfactant therapy on clinical outcomes of COVID-19 patients with ARDS: a systemic review and meta-analysis","volume":"16","author":"Mylavarapu M","year":"2024","unstructured":"Mylavarapu M, Dondapati VV, Dadana S, Sharma DD, Bollu B. Effect of surfactant therapy on clinical outcomes of COVID-19 patients with ARDS: a systemic review and meta-analysis. Cureus. 2024, 16:e56238. 10.7759\/cureus.56238","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/505367-nebulized-potassium-conjugated-linoleic-acid-k-cla-therapy-in-a-patient-with-chronic-obstructive-pulmonary-disease-and-centrilobular-emphysema-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:56:35Z","timestamp":1785153395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/505367-nebulized-potassium-conjugated-linoleic-acid-k-cla-therapy-in-a-patient-with-chronic-obstructive-pulmonary-disease-and-centrilobular-emphysema-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.113447","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}